Notice for infigratinib (Adjutor Healthcare Pty Ltd)
Active ingredients
infigratinib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Hard gelatin capsule
Indication
For the treatment of cholangiocarcinoma
Therapeutic area
Onclology